Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2020 Results Conference Call May 7, 2020 8:30 AM ET Company Participants Dr. Juan Sanchez - VP, Corporate Communications and IR Dr. Sharon Mates - Chairman and CEO Dr. Andrew Satlin - EVP and Chief Medical Officer Mark Neumann - EVP and Chief Commercial Officer Larry Hineline - EVP and CFO Conference Call Participants Charles Duncan - Cantor Fitzgerald Jessica Fye - JP Morgan Bo Chen - Evercore ISI Sumant Kulkarni - Canaccord Marc Goodman - SVB Leerink Brian A ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2019 Earnings Conference Call March 2, 2020 8:30 AM ET Company Participants Juan Sanchez - VP, Corporate Communications & IR Sharon Mates - Co-Founder, Chairman, CEO & President Mark Neumann - EVP & Chief Commercial Officer Andrew Satlin - EVP & Chief Medical Officer Lawrence Hineline - SVP, Finance, CFO, Treasurer and Assistant Secretary Conference Call Participants Charles Duncan - Cantor Fitzgerald Marc Goodman - SVB Leerink Umer Raffat - Evercore Jessica F ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2019 Earnings Conference Call November 5, 2019 8:30 AM ET Company Participants Juan Sanchez - VP, Corporate Communications & IR Sharon Mates - Co-Founder, Chairman, CEO & President Mark Neumann - EVP & Chief Commercial Officer Andrew Satlin - EVP & Chief Medical Officer Lawrence Hineline - SVP, Finance, CFO, Treasurer and Assistant Secretary Conference Call Participants Charles Duncan - Cantor Fitzgerald Jessica Fye - JPMorgan Chase & Co. Andrew Tsai - Jefferi ...

Intra-Cellular Therapies, Inc (NASDAQ:ITCI) Q1 2019 Earnings Conference Call May 8, 2019 8:30 AM ET Company Participants Juan Sanchez – Vice President of Investor Relations Sharon Mates – Chairman and Chief Executive Officer Mark Neumann – Executive Vice President and Chief Commercial Officer Andrew Satlin – Executive Vice President and Chief Medical Officer Larry Hineline – Senior Vice President and Chief Financial Officer Kimberly Vanover – Senior Vice President of Early Stage Clinical Development and Tra ...

Intra-Cellular T H E R A P I E S Corporate Presentation Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern our product candidates, our development efforts, our collaborations, our technology, our intellectual property, our financial condition, our plans and our development programs. These statements involve risks, uncertainties and assumptions, and are based on the ...